• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

SHPG:US

243.1700 USD 1.3300 0.54%

As of 20:10:00 ET on 08/27/2014.

Snapshot for Shire PLC (SHPG)

Open: 243.9500 Day's Range: 242.5600 - 244.2400 Volume: 482,400
Previous Close: 244.5000 52wk Range: 109.8200 - 258.5500 1-Yr Rtn: +120.35%

Stock Chart for SHPG

No chart data available.
  • SHPG:US 243.1700
  • 1D
  • 1M
  • 1Y
244.5000
Interactive SHPG Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for SHPG

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) 24.8895
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) 9.7700
Est. PEG Ratio 2.0061
Market Cap (M USD) 47,787.97
Shares Outstanding (M) 196.52
30 Day Average Volume 1,827,373
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield 0.09%
Cash Dividend (USD) 0.1149
Dividend Ex-Date 09/03/2014
5 Year Dividend Growth 15.00%
Next Earnings Announcement 10/24/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for SHPG

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for SHPG

Shire PLC markets, licenses and develops prescription medicines. The Group focuses its operations on attention deficit and hyperactivity disorders, human genetic therapies, gastrointestinal, and renal diseases.

Flemming OrnskovChief Executive OfficerJames BowlingInterim CFO/Senior VP/Controller
Tatjana MaySecretary/General CounselJeff PoultonHead:Investor Relations
More Company Profile & Key Executives for SHPG

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil